Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

This publication has 27 references indexed in Scilit:

• Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes
  Leukemia, 2003
• Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
  Blood, 2002
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
  Oncogene, 2002
• The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell lines
  Oncogene, 2002
• DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
  Nature, 2002
• Hypermethylation of gene promoters in hematological neoplasia
  Hematological Oncology, 2002
• Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development
  Journal of Clinical Investigation, 2001
• Methylation of the p15^INK4B gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation
  British Journal of Haematology, 2001
• Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis
  The EMBO Journal, 2000
• Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas
  Oncogene, 1997